Talis Biomedical Corporation announces the appointment of Roger Moody as the company’s Chief Financial Officer

By May 4, 2020 No Comments

Roger is an accomplished finance executive who comes with a wealth of experience in finance operations. Before joining Talis, Roger was CFO at Clinical Genomics, a colorectal cancer diagnostics company. Roger has also held leadership roles at Glysure Limited, a UK-based company specializing in continuous glucose monitoring, as well as CFO positions at Nanosphere, Inc. and Medsn, Inc. Roger earned a B.S. in Finance from Syracuse University and an MBA with focus in Finance from the University of Chicago Booth School of Business.

Leave a Reply